D. E. Shaw & Co., Inc. Galapagos Nv Put Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $761,500 - $1.12 Million	10,000 New	10,000 $771,000
Q4 2020 Feb 16, 2021	SELL	$96.85 - $148.25 $968,500 - $1.48 Million	-10,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$146.12 - $215.82 $1.46 Million - $2.16 Million	10,000 New	10,000 $2.07 Million

16.5M

77.1K

57.2K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.72B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.